1. FDA approves Sarepta’s DMD drug that it had previously rejected — Biogen chalks up another failure — The House passes the Lower Drug Costs Now Act, but it’s unlikely to become law — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Greiner Bio-One

Anonymous board for Greiner Bio-One


Sort By:
Title
Replies Views
Last Message ↓
  1. Anonymous
    Replies:
    0
    Views:
    9,076

Thread Display Options

Loading...